Xin Sun
- Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional surveyBy Ya Chen, Wan Yao, Jian Kang, Bo Cai, Xin Zhou, Zheng Liu, Ping Chen, De Sun, Jing Zheng, Guo Wang, Yu Feng and Yong XuYa Chen1Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, ChinaWan Yao1Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, ChinaJian Kang2Pulmonary and Critical Care Medicine, The First Hospital Affiliated To Chinese Medical University, Shenyang, ChinaBo Cai3Pulmonary and Critical Care Medicine, Peking Union Hospital, Beijing, ChinaXin Zhou4Pulmonary and Critical Care Medicine, The First People's Hospital in Shanghai, Shanghai, ChinaZheng Liu5Pulmonary and Critical Care Medicine, China Oil and Gas Group Central Hospital, Langfang, ChinaPing Chen6Pulmonary and Critical Care Medicine, Shenyang Military General Hospital, Chinese People's Liberation Army, Shenyang, ChinaDe Sun7Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Mongolia Medical College, Innermongila, Baotou, ChinaJing Zheng8Institute of Respiratory Disease, Guangzhou, Institute of Respiratory Disease, Guangzhou, Guangzhou, ChinaGuo Wang9Pulmonary and Critical Care Medicine, Beijing Jingmei Group General Hospital, Beijing, ChinaYu Feng10Pulmonary and Critical Care Medicine, Huaxi Hospital, Sichuan University, Beijing, ChinaYong Xu11Pulmonary and Critical Care Medicine, Tongji Hospital Affiliated in Huazhong Science and Technology University, Wuhan, China
- Agreement between patient-reported and chart documented outcomes: Case study in COPDBy Caitlyn Solem, Lavanya Sudharshan, Shawn Sun, Cynthia Macahilig, Monica Katyal, Xin Gao and Andrew ShorrCaitlyn Solem1Health Economics and Outcomes Research, Pharmerit North America, Bethesda, MA, United StatesLavanya Sudharshan1Health Economics and Outcomes Research, Pharmerit North America, Bethesda, MA, United StatesShawn Sun2Health Economics and Outcomes Research, Forest Research Institute, Jersey City, NJ, United StatesCynthia Macahilig3Research Operations, Medical Data Analytics, Parsippany, NJ, United StatesMonica Katyal3Research Operations, Medical Data Analytics, Parsippany, NJ, United StatesXin Gao1Health Economics and Outcomes Research, Pharmerit North America, Bethesda, MA, United StatesAndrew Shorr4Pulmonary Critical Care, Washington Hospital Center and Georgetown University, Washington, DC, United States
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaBy Shenjie Tang, Lan Yao, Xiaohui Hao, Xia Zhang, Gang Liu, Xin Liu, Meiying Wu, Linhai Zen, Hua Sun, Yidian Liu, Jin Gu, Feishen Lin, Xiafang Wang and Zhanjun ZhangArticle | Published in 2014 in European Respiratory JournalShenjie Tang1Tuberculosis Multidisciplinary Center for Diagnosis and Treatment, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, China2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyLan Yao2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyXiaohui Hao2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyXia Zhang3Nanjing Chest Hospital, Nanjing, ChinaGang Liu4Anhui Chest Hospital, Hefei, ChinaXin Liu5Henan Chest Hospital, Zhengzhou, ChinaMeiying Wu6Souzhou Fifth People's Hospital, Souzhou, ChinaLinhai Zen2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaHua Sun7Shanghai Minhang Center for Disease Control and Prevention, Shanghai, ChinaYidian Liu2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaJin Gu2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaFeishen Lin3Nanjing Chest Hospital, Nanjing, ChinaXiafang Wang6Souzhou Fifth People's Hospital, Souzhou, ChinaZhanjun Zhang2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaBy Shenjie Tang, Lan Yao, Xiaohui Hao, Xia Zhang, Gang Liu, Xin Liu, Meiying Wu, Linhai Zen, Hua Sun, Yidian Liu, Jin Gu, Feishen Lin, Xiafang Wang and Zhanjun ZhangShenjie Tang1Tuberculosis Multidisciplinary Center for Diagnosis and Treatment, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, China2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyLan Yao2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyXiaohui Hao2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China8Authors contributed equallyXia Zhang3Nanjing Chest Hospital, Nanjing, ChinaGang Liu4Anhui Chest Hospital, Hefei, ChinaXin Liu5Henan Chest Hospital, Zhengzhou, ChinaMeiying Wu6Souzhou Fifth People's Hospital, Souzhou, ChinaLinhai Zen2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaHua Sun7Shanghai Minhang Center for Disease Control and Prevention, Shanghai, ChinaYidian Liu2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaJin Gu2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaFeishen Lin3Nanjing Chest Hospital, Nanjing, ChinaXiafang Wang6Souzhou Fifth People's Hospital, Souzhou, ChinaZhanjun Zhang2Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
- Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary diseaseBy Feng Li, Pengyu Zhang, Min Zhang, Li Liang, Xiaoyuan Sun, Aihua Bao, Min Li, Yueqin Tang, Jicheng Gong, Jim (Junfeng) Zhang, Ian Adcock, Kian Fan Chung and Xin ZhouFeng Li1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaPengyu Zhang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaMin Zhang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaLi Liang3Dept of Respiratory Medicine, Shanghai Third People Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaXiaoyuan Sun1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaAihua Bao1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaMin Li1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaYueqin Tang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaJicheng Gong4Division of Environmental Sciences & Policy, Duke University, Durham, United StatesJim (Junfeng) Zhang4Division of Environmental Sciences & Policy, Duke University, Durham, United StatesIan Adcock5Airway Diseases Section, National Heart and Lung Institute, Imperial College London, London, United KingdomKian Fan Chung5Airway Diseases Section, National Heart and Lung Institute, Imperial College London, London, United KingdomXin Zhou1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, China
- Lung Stem Cells in Development, Health and DiseaseEdited by Marko Z. Nikolić and Brigid L.M. HoganBook | Published in 2021DOI: 10.1183/2312508X.erm9121ISBN (electronic): 978-1-84984-134-4
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.